Search research articles
Contact Us
Filters
Showing results (11-20 of 588) with videos related to
Page
of 59
Sort By:
Inflammation & Allergy Drug Targets
|
October 5, 2010
The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
Manjit Braitch, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
September 22, 2009
Cannabinoids and experimental models of multiple sclerosis
Ilona Kubajewska, Cris S Constantinescu
Current Neurology and Neuroscience Reports
|
July 12, 2012
Cost-effectiveness of disease-modifying therapies in multiple sclerosis
Ali Manouchehrinia, Cris S Constantinescu
Current Eye Research
|
December 28, 1999
Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS)
C S Constantinescu, E Lavi
European Journal of Neurology
|
April 11, 2018
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
C S Constantinescu, P Gershkovich
Neurorehabilitation and Neural Repair
|
April 12, 2002
Possible role of corticosteroids in nervous system plasticity: improvement in amblyopia after optic neuritis in the fellow eye treated with steroids
C S Constantinescu, I Gottlob
Immunobiology
|
February 16, 2010
Cannabinoids and the immune system: an overview
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
June 15, 2010
Relationship between cannabinoids and the immune system. Special Issue 8, 2010 Introduction
Wilhelm Schwaeble, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
April 30, 2013
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
Radu Tanasescu, Cris S Constantinescu
Page
of 59
Search research articles
Search
Showing results (11-20 of 588) with videos related to
Sort By:
Page
of 59
Inflammation & Allergy Drug Targets
|
October 5, 2010
The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
Manjit Braitch, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
September 22, 2009
Cannabinoids and experimental models of multiple sclerosis
Ilona Kubajewska, Cris S Constantinescu
Current Neurology and Neuroscience Reports
|
July 12, 2012
Cost-effectiveness of disease-modifying therapies in multiple sclerosis
Ali Manouchehrinia, Cris S Constantinescu
Current Eye Research
|
December 28, 1999
Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS)
C S Constantinescu, E Lavi
European Journal of Neurology
|
April 11, 2018
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
C S Constantinescu, P Gershkovich
Neurorehabilitation and Neural Repair
|
April 12, 2002
Possible role of corticosteroids in nervous system plasticity: improvement in amblyopia after optic neuritis in the fellow eye treated with steroids
C S Constantinescu, I Gottlob
Immunobiology
|
February 16, 2010
Cannabinoids and the immune system: an overview
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
June 15, 2010
Relationship between cannabinoids and the immune system. Special Issue 8, 2010 Introduction
Wilhelm Schwaeble, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
April 30, 2013
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
Radu Tanasescu, Cris S Constantinescu
Page
of 59